Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Evaluating the Association of Topotecan and Lapatinib in Early Recurrent (Less Than 12 Months)Ovarian or Peritoneal Cancer Patients After First Line of Platinum-Based Chemotherapy

NCT00888810 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT00888810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00888810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Evaluating the Association of Topotecan and Lapatinib in Early Recurrent (Less Than 12 Months)Ovarian or Peritoneal Cancer Patients After First Line of Platinum-Based Chemotherapy
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2008
Completion date
Not reported
Enrollment
39 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapy, ovarian, relapse